相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A population-based analysis of attributable hospitalisation costs of invasive fungal diseases in haematological malignancy patients using data linkage of state-wide registry and costing databases: 2009-2015
Jake C. Valentine et al.
MYCOSES (2020)
Healthcare burden of probable and proven invasive mucormycosis: a multi-centre cost-of-illness analysis of patients treated in tertiary care hospitals between 2003 and 2016
S. M. Heimann et al.
JOURNAL OF HOSPITAL INFECTION (2019)
Impact of choice, timing, sequence and combination of broad-spectrum antibiotics on the outcome of allogeneic haematopoietic stem cell transplantation
F. Farowski et al.
BONE MARROW TRANSPLANTATION (2018)
FungiScope™ - Global Emerging Fungal Infection Registry
Danila Seidel et al.
MYCOSES (2017)
Posaconazole Plasma Concentrations on Days Three to Five Predict Steady-State Levels
Juergen Prattes et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
An estimation of burden of serious fungal infections in France
J. -P. Gangneux et al.
JOURNAL DE MYCOLOGIE MEDICALE (2016)
A cohort study on breakthrough invasive fungal infections in high-risk patients receiving antifungal prophylaxis
Lena M. Biehl et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Safety and Efficacy of Intermittent Intravenous Administration of High-Dose Micafungin
Dionysis Neofytos et al.
CLINICAL INFECTIOUS DISEASES (2015)
A cost and resource utilization analysis of micafungin bridging for hemato-oncological high-risk patients undergoing allogeneic stem cell transplantation
Sebastian M. Heimann et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2015)
Candidemia in the intensive care unit: analysis of direct treatment costs and clinical outcome in patients treated with echinocandins or fluconazole
S. M. Heimann et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2015)
Clostridium Difficile Infection in Patients with Acute Myelogenous Leukemia and in Patients Undergoing Allogeneic Stem Cell Transplantation: Epidemiology and Risk Factor Analysis
Maria J. G. T. Vehreschild et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Feasibility and effectiveness of posaconazole prophylaxis in combination with micafungin bridging for patients undergoing allogeneic stem cell transplantation: A 6-yr analysis from the cologne cohort for neutropenic patients
Maria J. G. T. Vehreschild et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2014)
Different doses of micafungin for prophylaxis of invasive fungal diseases in hemato-oncological high-risk patients: a web-based non-interventional trial in four large university hospitals in Germany
S. M. Heimann et al.
TRANSPLANT INFECTIOUS DISEASE (2014)
Indications and outcomes of antifungal therapy in French patients with haematological conditions or recipients of haematopoietic stem cell transplantation
Raoul Herbrecht et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
a Treatment cost of invasive fungal disease (Ifd) in patients with acute myelogenous leukaemia (Aml) or myelodysplastic syndrome (Mds) in German hospitals
C. T. Rieger et al.
MYCOSES (2012)
Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation
David I. Marks et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation
John R. Wingard et al.
BLOOD (2010)
Management of Drug and Food Interactions with Azole Antifungal Agents in Transplant Recipients
Elizabeth Dodds-Ashley
PHARMACOTHERAPY (2010)
Mortality, length of hospitalization, and costs associated with invasive fungal infections in high-risk patients
Joseph Menzin et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2009)
Epidemiology and Outcome of Invasive Fungal Infection in Adult Hematopoietic Stem Cell Transplant Recipients: Analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance Registry
D. Neofytos et al.
CLINICAL INFECTIOUS DISEASES (2009)
Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
Ben De Pauw et al.
CLINICAL INFECTIOUS DISEASES (2008)
German recommendations on health economic evaluation: Third and updated version of the Hanover Consensus
J. -Matthias Graf von der Schulenburg et al.
VALUE IN HEALTH (2008)
Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation
JAH van Burik et al.
CLINICAL INFECTIOUS DISEASES (2004)
Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus
S Ascioglu et al.
CLINICAL INFECTIOUS DISEASES (2002)
分享论文
